Alexander Yermanos

Alexander Yermanos

Auto-generated profile, based on publicly available information

Alexander Yermanos

University Medical Center Utrecht Center for Translational Immunology Lundlaan 6 , 3584 EA Utrecht

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2022 in Science Translational Medicine
Verified
Journal Article
Closed access
DFDavid Frieser
David Frieser
APAurora Pignata
Aurora Pignata
LKLeila Khajavi
Leila Khajavi
DSDanielle Shlesinger
Danielle Shlesinger
CGCarmen Gonzalez-Fierro
Carmen Gonzalez-Fierro
RLRoland S. Liblau
Roland S. Liblau
The mechanisms underlying the chronicity of autoimmune diseases of the central nervous system (CNS) are largely unknown. In particular, it is unclear whether tissue-resident memory T cells (T RM ) contribute to lesion pathogenesis during chronic CNS autoimmunity. Here, we observed that a high frequency of brain-infiltrating CD8 + T cells exhibit a T RM -like phenotype in human autoimmune encephalitis. Using mouse models of neuronal autoimmunity and a combination of T single-cell transcriptomics, high-dimensional flow cytometry, and histopathology, we found that pathogenic CD8 + T cells behind the blood-brain barrier adopt a characteristic T RM differentiation program, and we revealed their phenotypic and functional heterogeneity. In the diseased CNS, autoreactive tissue-resident CD8 + T cells sustained focal neuroinflammation and progressive loss of neurons, independently of recirculating CD8 + T cells. Consistently, a large fraction of autoreactive tissue-resident CD8 + T cells exhibited proliferative potential as well as proinflammatory and cytotoxic properties. Persistence of tissue-resident CD8 + T cells in the CNS and their functional output, but not their initial differentiation, were crucially dependent on CD4 + T cells. Collectively, our results point to tissue-resident CD8 + T cells as essential drivers of chronic CNS autoimmunity and suggest that therapies targeting this compartmentalized autoreactive T cell subset might be effective for treating CNS autoimmune diseases.

13 April 2022 in Science Translational Medicine
Verified
Journal Article
Closed access
IVIlena Vincenti
Ilena Vincenti
NPNicolas Page
Nicolas Page
KSKarin Steinbach
Karin Steinbach
AYAlexander Yermanos
Alexander Yermanos
SLSylvain Lemeille
Sylvain Lemeille
DMDoron Merkler
Doron Merkler
In chronic inflammatory diseases of the central nervous system (CNS), immune cells persisting behind the blood-brain barrier are supposed to promulgate local tissue destruction. The drivers of such compartmentalized inflammation remain unclear, but tissue-resident memory T cells (T RM ) represent a potentially important cellular player in this process. Here, we investigated whether resting CD8 + T RM persisting after cleared infection with attenuated lymphocytic choriomeningitis virus (LCMV) can initiate immune responses directed against cognate self-antigen in the CNS. We demonstrated that time-delayed conditional expression of the LCMV glycoprotein as neo-self-antigen by glia cells reactivated CD8 + T RM . Subsequently, CD8 + T RM expanded and initiated CNS inflammation and immunopathology in an organ-autonomous manner independently of circulating CD8 + T cells. However, in the absence of CD4 + T cells, TCF-1 + CD8 + T RM failed to expand and differentiate into terminal effectors. Similarly, in human demyelinating CNS autoimmune lesions, we found CD8 + T cells expressing TCF-1 that predominantly exhibited a T RM -like phenotype. Together, our study provides evidence for CD8 + T RM -driven CNS immunopathology and sheds light on why inflammatory processes may evade current immunomodulatory treatments in chronic autoimmune CNS conditions.

14 January 2022 in Cell Reports Methods
Verified
Journal Article
Open access
EAErik Aznauryan
Erik Aznauryan
AYAlexander Yermanos
Alexander Yermanos
EKElvira Kinzina
Elvira Kinzina
ADAnna Devaux
Anna Devaux
EKEdo Kapetanovic
Edo Kapetanovic
SRSai T. Reddy
Sai T. Reddy
Existing approaches to therapeutic gene transfer are marred by the transient nature of gene expression following non-integrative gene delivery and by safety concerns due to the random mechanism of viral-mediated genomic insertions. The disadvantages of these methods encourage future research in identifying human genomic sites that allow for durable and safe expression of genes of interest. We conducted a bioinformatic search followed by the experimental characterization of human genomic sites, identifying two that demonstrated the stable expression of integrated reporter and therapeutic genes without malignant changes to the cellular transcriptome. The cell-type agnostic criteria used in our bioinformatic search suggest widescale applicability of identified sites for engineering of a diverse range of tissues for clinical and research purposes, including modified T cells for cancer therapy and engineered skin to ameliorate inherited diseases and aging. In addition, the stable and robust levels of gene expression from identified sites allow for the industry-scale biomanufacturing of proteins in human cells.

9 April 2021 in NAR Genomics and Bioinformatics
Verified
Journal Article
Open access
PDF file
AYAlexander Yermanos
Alexander Yermanos
AAAndreas Agrafiotis
Andreas Agrafiotis
RKRaphael Kuhn
Raphael Kuhn
DRDamiano Robbiani
Damiano Robbiani
JYJosephine Yates
Josephine Yates
SRSai T Reddy
Sai T Reddy
High-throughput single-cell sequencing (scSeq) technologies are revolutionizing the ability to molecularly profile B and T lymphocytes by offering the opportunity to simultaneously obtain information on adaptive immune receptor repertoires (VDJ repertoires) and transcriptomes. An integrated quantification of immune repertoire parameters, such as germline gene usage, clonal expansion, somatic hypermutation and transcriptional states opens up new possibilities for the high-resolution analysis of lymphocytes and the inference of antigen-specificity. While multiple tools now exist to investigate gene expression profiles from scSeq of transcriptomes, there is a lack of software dedicated to single-cell immune repertoires. Here, we present Platypus, an open-source software platform providing a user-friendly interface to investigate B-cell receptor and T-cell receptor repertoires from scSeq experiments. Platypus provides a framework to automate and ease the analysis of single-cell immune repertoires while also incorporating transcriptional information involving unsupervised clustering, gene expression and gene ontology. To showcase the capabilities of Platypus, we use it to analyze and visualize single-cell immune repertoires and transcriptomes from B and T cells from convalescent COVID-19 patients, revealing unique insight into the repertoire features and transcriptional profiles of clonally expanded lymphocytes. Platypus will expedite progress by facilitating the analysis of single-cell immune repertoire and transcriptome sequencing.

2 November 2021 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
DNDaniel Neumeier
Daniel Neumeier
APAlessandro Pedrioli
Alessandro Pedrioli
AGAlessandro Genovese
Alessandro Genovese
ISIoana Sandu
Ioana Sandu
RERoy Ehling
Roy Ehling
AYAlexander Yermanos
Alexander Yermanos
Plasma cells and their secreted antibodies play a central role in the long‐term protection against chronic viral infection. However, due to experimental limitations, a comprehensive description of linked genotypic, phenotypic, and antibody repertoire features of plasma cells (gene expression, clonal frequency, virus specificity, and affinity) has been challenging to obtain. To address this, we performed single‐cell transcriptome and antibody repertoire sequencing of the murine BM plasma cell population following chronic lymphocytic choriomeningitis virus infection. Our single‐cell sequencing approach recovered full‐length and paired heavy‐ and light‐chain sequence information for thousands of plasma cells and enabled us to perform recombinant antibody expression and specificity screening. Antibody repertoire analysis revealed that, relative to protein immunization, chronic infection led to increased levels of clonal expansion, class‐switching, and somatic variants. Furthermore, antibodies from the highly expanded and class‐switched (IgG) plasma cells were found to be specific for multiple viral antigens and a subset of clones exhibited cross‐reactivity to nonviral and autoantigens. Integrating single‐cell transcriptome data with antibody specificity suggested that plasma cell transcriptional phenotype was correlated to viral antigen specificity. Our findings demonstrate that chronic viral infection can induce and sustain plasma cell clonal expansion, combined with significant somatic hypermutation, and can generate cross‐reactive antibodies.

26 August 2022 in Genes & Immunity
Verified
Journal Article
Open access
PDF file
DSDanielle Shlesinger
Danielle Shlesinger
KHKai-Lin Hong
Kai-Lin Hong
GSGhazal Shammas
Ghazal Shammas
NPNicolas Page
Nicolas Page
ISIoana Sandu
Ioana Sandu
AYAlexander Yermanos
Alexander Yermanos
Adaptive immune repertoires are composed by the ensemble of B and T-cell receptors within an individual, reflecting both past and current immune responses. Recent advances in single-cell sequencing enable recovery of the complete adaptive immune receptor sequences in addition to transcriptional information. Here, we recovered transcriptome and immune repertoire information for polyclonal T follicular helper cells following lymphocytic choriomeningitis virus (LCMV) infection, CD8+ T cells with binding specificity restricted to two distinct LCMV peptides, and B and T cells isolated from the nervous system in the context of experimental autoimmune encephalomyelitis. We could relate clonal expansion, germline gene usage, and clonal convergence to cell phenotypes spanning activation, memory, naive, antibody secretion, T-cell inflation, and regulation. Together, this dataset provides a resource for immunologists that can be integrated with future single-cell immune repertoire and transcriptome sequencing datasets.